in this issue
Regions :: North America :: U.S.
Lonza Expands, Revamps Former Cambrex Site at Hopkinton, MA (update)
8:15 AM MDT | April 23, 2009 | Alex Scott
Lonza, one of the world’s most successful contract fine chemical companies, says it has completed the build out of a new mid-scale volume biologic drugs manufacturing facility at Hopkinton, MA. In parallel, Lonza says it has also revamped the entire Hopkinton site-formerly owned by Cambrex-to enhance infrastructure reliability including electricity and waste streams, and increase operational efficiency while meeting cGMP requirements. The new facility, a 2,000-liter microbial fermentation plant, is complemented by a highly flexible purification area capable...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee